By the summer of 2024, the Podorozhnyk pharmacy chain plans to expand its network to 2 thousand pharmacies, said Taras Kolyada, CEO of the chain.
“We currently have 1763 pharmacies. In 2023, we opened 400 new pharmacies. By the summer of 2024, we will grow to 2 thousand pharmacies,” he said in an interview with Forbes.
Mr. Kolyada said that the chain is currently expanding at a fairly rapid pace: “In 2019, we opened 486 pharmacies, and now 400 pharmacies a year is a normal rhythm for us.”
At the same time, he noted that “we usually have 150 outlets in back closer – somewhere we are doing repairs and looking for people, somewhere we are signing a contract or waiting for the lease with the previous owner of the premises to end.”
“Landlords perceive a pharmacy as a stable business and are ready to cooperate. We are building the coverage of the country. For us, the key is to penetrate the regions, small towns from Chop to Seredyna-Buda, from Reni to the north of Chernihiv region,” he said.
In addition, Kolyada said that in 2023, sales of Podorozhnyk across all channels increased by 40-50% compared to 2022.
At the same time, Kolyada predicts that in general, “the trend for network expansion in Ukraine is still there, but the redistribution of the market will favor system operators.”
According to Kolyada, the average investment in opening a pharmacy is up to UAH 3.5 million.
Pharmacy sales in Ukraine in April 2019 in monetary terms rose by 16.1% compared with April 2018, to UAH 8.073 billion, but decreased by 3.7% in natural terms, to 139.8 million packages.
According to the Apteka edition, with reference to data from the analytical system PharmXplorer/Pharmstandard, in April 2019 sales of medicines in monetary terms grew by 14.6% compared to April 2018, to UAH 6.703 billion, in natural terms by 4%, to 88.9 million packs.
The Ukrainian pharmaceutical companies Farmak, the corporations Arterium and Darnitsa, as well as Teva (Israel) and Sanofi (France) are among the top five marketing organizations.
As reported, in 2018 pharmacy sales in Ukraine in monetary terms increased by 23.4% compared with 2017, to UAH 84.574 billion, sales in natural terms for the period decreased by 0.84% compared with 2017, to 1.52 billion packages.
TAS pharmacy chain (TAS Pharma LLC), part of TAS Group, intends to acquire another 60 pharmacies in the near future, increasing their number to 153 by February 2019. According to a press release from the network, TAS has begun a deal to acquire a pharmaceutical network of 26 pharmacies. In addition, negotiations are underway on the acquisition of another 34 pharmacies owned by two participants in the domestic pharmaceutical market.
“The acquisition of 60 pharmacies will allow us to increase our company’s share in the pharmaceutical market of Ukraine, improve its efficiency and strengthen our position in the top 20 pharmacy chains of the country,” the press service said citing director general of the chain Valeriy Hudzenko.
TAS Group was founded in 1998. It has assets in financial and industrial sectors, agriculture, real estate, pharmaceuticals, and venture projects. The financial sector of the group includes TAScombank, Universal Bank, VS Bank, two insurance companies and a number of other organizations. The founder and main shareholder of the group is Sergiy Tigipko.
Pharmacy sales in Ukraine in January-October 2018 in monetary terms increased by 28% compared to the same period in 2017, to UAH 68.665 billion. Business Credit company told Interfax-Ukraine, in natural terms sales for the specified period remained unchanged, being 1.229 million packages, while the weighted average price rose by 28%, to UAH 55.60 per unit of goods.
According to the company, retail sales of medicines in January-October in monetary terms increased by 30%, to UAH 56.732 billion, in natural terms by 9%, to 833.893 million packages. The weighted average price of medicines in January-October 2018 was UAH 68 per product unit.
As reported, in January-September 2018 pharmacy sales in Ukraine in monetary terms were up by 30% compared to the same period in 2017 and amounted to UAH 61.788 billion, while sales in kind by 1%, to 1.124 billion packages.
Retail sales of drugs in January-September 2018 in monetary terms grew by 32%, to UAH 50.805 billion, in natural terms by 10%, to 754.352 million packages.
Pharmacy sales in Ukraine in January-September 2018 in monetary terms increased by 30% compared to the same period in 2017, to UAH 61.788 billion. Business Credit company told Interfax-Ukraine, in natural terms sales for the specified period increased by a mere 1%, to 1.124 million packs, while the weighted average price rose by 28%, to UAH 55 per unit of goods. According to the company, retail sales of medicines in January-September in monetary terms increased by 32%, to UAH 50.805 billion, in natural terms by 10%, to 754.352 million packs. The weighted average price of medicines in the first nine months of 2018 was UAH 67.4 per product unit.
As reported, in the first half of 2018 pharmacy sales in Ukraine in monetary terms were up by 36% compared to the same period in 2017 and amounted to UAH 43.011 billion, while sales in real terms by 5%, to 780.737 million packs.
Retail sales of drugs in the first half of the year in monetary terms grew by 38%, to UAH 35.454 billion, in natural terms by 16%, to 530.846 million packs.
Pharmacy sales in Ukraine in monetary terms in January-August 2018 increased by 32% compared to the same period in 2017, to UAH 55.233 billion. Business Credit company told Interfax-Ukraine sales in natural terms for the specified period rose by 2%, to 1.005 million packages, while the weighted average price increased by 29%, to UAH 55 per unit of goods.
According to the company, retail sales of medicines in January-August in monetary terms grew by 34%, to UAH 45.42 billion, in natural terms by 13%, to 679.897 million packages.
As reported, in the first half of 2018 pharmacy sales in Ukraine in monetary terms were up by 36% compared to the same period in 2017 and amounted to UAH 43.011 billion, while sales in natural terms by 5%, to 780.737 million packs.
Retail sales of drugs in the first half of the year in money terms increased by 38%, to UAH 35.454 billion, in natural terms by 16%, to 530.846 million packs.
